Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France

In face of evidence of rapid waning of vaccine effectiveness against Omicron and its sub-lineages, a second booster with mRNA vaccines was recommended for the most vulnerable in France. We used a test negative design to estimate the effectiveness of the second booster relative to the first booster a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamandjou, Cynthia, Auvigne, Vincent, Schaeffer, Justine, Vaux, Sophie, Parent du Châtelet, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027956/
https://www.ncbi.nlm.nih.gov/pubmed/36964001
http://dx.doi.org/10.1016/j.vaccine.2023.03.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027956/
https://www.ncbi.nlm.nih.gov/pubmed/36964001
http://dx.doi.org/10.1016/j.vaccine.2023.03.031

Ejemplares similares